Old; Lloyd

Patent Applications and Registrations

Patent applications and USPTO patent grants for Old; Lloyd.The latest application filed is for "a34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same".

Company Profile

0.14.10

Old; Lloyd - New York NY US
Old; Lloyd - US
Old; Lloyd - NY NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy Grant 8,603,474 - Ritter , et al. December 10, 2	2013-12-10
A34 and A33-like 3 DNA protein, antibodies thereto and methods of treatment using same Grant 8,440,807 - Scanlan , et al. May 14, 2	2013-05-14
A34 And A33-like 3 Dna Protein, Antibodies Thereto And Methods Of Treatment Using Same App 20120039892 - Scanlan; Matthew ; et al.	2012-02-16
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 8,071,717 - Jager , et al. December 6, 2	2011-12-06
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20100278850 - Jager; Dirk ; et al.	2010-11-04
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof Grant 7,795,409 - Jager , et al. September 14, 2	2010-09-14
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,622,568 - Jager , et al. November 24, 2	2009-11-24
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof App 20090203123 - Jager; Dirk ; et al.	2009-08-13
A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same Grant 7,521,543 - Scanlan, legal representative , et al. April 21,	2009-04-21
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20080177031 - Jager; Dirk ; et al.	2008-07-24
Methods And Compositions For Increased Priming Of T-cells Through Cross-presentation Of Exogenous Antigens App 20080171059 - Howland; Shanshan Wu ; et al.	2008-07-17
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,354,992 - Jager , et al. April 8, 2	2008-04-08
A34 and a33-Like 3dna, proteins, antibodies thereto and methods of treatment using same App 20060292154 - Scanlan; Matthew ; et al.	2006-12-28
Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses Grant 7,132,507 - Jager , et al. November 7, 2	2006-11-07
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,911,529 - Jager , et al. June 28, 2	2005-06-28
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20050063981 - Jager, Dirk ; et al.	2005-03-24
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,774,226 - Jager , et al. August 10, 2	2004-08-10
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20040126398 - Jager, Dirk ; et al.	2004-07-01
Method for determining protein component in a biological sample App 20030040027 - Ritter, Gerd ; et al.	2003-02-27
Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses App 20030017547 - Jager, Dirk ; et al.	2003-01-23
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,448,073 - Jager , et al. September 10, 2	2002-09-10
Monoclonal antibodies to melanoma cells Grant 5,009,995 - Albino , et al. April 23, 1	1991-04-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.